On Jul 29, 2021 Topas Therapeutics closed a Series B round and raised €18,000,000 from BioMedPartners, Boehringer Ingelheim Venture Fund, EMBL Ventures, Epidarex Capital, Evotec, Gimv, Vesalius Biocapital Partners, featuring lead investors .

About the company: Topas Therapeutics is located at Germany, Europe.
“Topas Therapeutics GmbH”

Company website: topas-therapeutics.com/topas/home/